Secondary end points included no receipt of immunoglobulin-replacement therapy, the presence of protective titers to tetanus or pneumococcal vaccines, and sustained discontinuation of fungal or viral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback